Non-invasive biomarkers for monitoring the fibrogenic process in liver: A short survey

doi:10.3748/wjg.15.2433

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9644)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

783

HTML

7827

Figures (1-2)

591

Tables (1-3)

443

Sum=9644

May 28, 2009 (publication date) through Nov 15, 2025

Times Cited of This Article

Times Cited (45)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Editorial

World J Gastroenterol. May 28, 2009; 15(20): 2433-2440
Published online May 28, 2009. doi: 10.3748/wjg.15.2433

Table 1 Class I biomarkers of liver fibrogenesis

	Specimen			Method
	Serum	Urine	Liver biopsy	Method
Extracellular matrix-related enzymes
Enzyme
Prolyl hydroxylase	+	-	+	Radioenzymatic, RIA
Monoamine-oxidase	+	-	(+)	Enzymatic
Lysyl oxidase	+	-	+	RIA
Lysyl hydroxylase	+	-	-	RIA
Galactosylhydroxylysyl-glucosyltransferase	+	-	+	RIA
Collagen peptidase	+	-	+	Enzymatic
N-Acetyl-β-D-glucosaminidase	+	+	+	Enzymatic
Collagen fragments and split products
Type of collagen
Type I-procollagen
N-terminal propeptide (PINP)	+	-	+	ELISA
C-terminal propeptide (PICP)	+	-	+	RIA
Type III-Procollagen
Intact Procollagen	+	-	-	RIA
N-terminal propeptide (PIIINP)
Complete propeptide (Col 1-3)	+	-	-	RIA
Globular domain of Propeptide (Col-1)	+	-	-	RIA
Type IV-Collagen
NC1-fragment (C-terminal) crosslinking domain (PIVP)	+	+	-	ELISA, RIA
7S domain ("7S Collagen")	+	+	-	RIA
Type VI-Collagen	+	+	+	RIA
Glycoproteins and matrix-metalloproteinase (inhibitors)
Marker
Laminin, P1-fragment	+	-	-	RIA, EIA
Undulin	+	-	-	EIA
Vitronectin	+	-	-	EIA
Tenascin	+	-	-	ELISA
YKL-40	+	-	+	RIA/ELISA
(pro)matrix metalloproteinase (MMP-2)	+	-	-	ELISA
Tissue inhibitor of metalloproteinases (TIMP-1, TIMP-2)	+	-	-	ELISA
sICAM-1 (soluble intercellular adhesion molecule, sCD54)
sVCAM-1 (soluble vascular cell adhesion molecule, sCD106)	+	-	-	ELISA
Glycosaminoglycans
Marker
Hyaluronic acid (Hyaluronan)	+	-	-	Radioligand assay ELISA
Molecular mediators
Marker
Transforming growth factor β (TGF-β)	+	-	+	ELISA
Connective tissue growth factor (CTGF/CCN2)	+	?	+	ELISA

Full Size Table

Table 2 Class II biomarkers of liver fibrogenesis

Index	Parameters	Chronic liver disease	Sensitivity (%)	Specificity (%)
PGAA-Index	Prothrombin time, γGT, apolipoprotein A1, α₂-macroglobulin	Alcohol	79	89
Bonacini-Index	ALT/AST-ratio, INR, platelet count	HCV	46	98
Sheth-Index	AST/ALT (De Ritis)	HCV	53	100
Park-Index		HCV	47	96
PGA-Index	Prothrombin time, γGT, apolipoprotein A1	Mixed	91	81
Fortunato-Score	Fibronectin, prothrombin time, PCHE, ALT, Mn-SOD, β-NAG	HCV		94
Fibrotest (Fibro-Score)	Haptoglobin, α₂-macroglobulin, apolipoprotein A1, γGT, bilirubin	HCV	75	85
Fibrotest (Fibro-Score)		HBV	75	85
Pohl-Score	AST/ALT-ratio, platelet count	HCV	41	99
Actitest	Fibrotest + ALT	HCV
Forns-Index	Age, platelet count, γGT, cholesterol	HCV	94	51
Wai-Index (APRI)	AST, platelet count	HCV	89	75
Rosenberg-Score (ELF-Score)	PIIINP, hyaluronan, TIMP-1	Mixed	90	41
Patel-Index (FibroSpect)	Hyaluronan, TIMP-1, α₂-macroglobulin	HCV	77	73
Sud-Index (fibrosis probability-index, FPI)	Age, AST, cholesterol, insulin resistance (HOMA), past alcohol intake	HCV	96	44
Leroy-Score	PIIINP, MMP-1	HCV	60	92
Fibrometer test	Platelet count, prothrombin index, AST, α₂-macro-globulin, hyaluronan, urea, age	Mixed	81	84
Hepascore	Bilirubin, γGT, hyaluronan, α₂-macroglobulin, age, gender	HCV	63	89
Testa-Index	Platelet count/spleen diameter-ratio	HCV	78	79
FIB-4	Platelet count, AST, ALT, age	HCV/HIV	70	74
FibroIndex	Platelet count, AST, γ-globulin	HCV	38	97

GGT: γ-glutamyltransferase; PIIINP: N-terminal propeptide of type III procollagen; TIMP: Tissue inhibitors of metalloproteinases; MMP: Matrix metalloproteinases; β-NAG: N-acetyl-β-glucosaminidase; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; INR: International normalized ratio.

Full Size Table

Table 3 Future candidate biomarkers of non-invasive diagnosis and follow-up of liver fibrogenesis

Biomarker	Specimen	Assay technology	Pathobiochemical basis
CTGF	Serum	Immunoassay	TGF-β induced expression in and secretion by hepatocytes and hepatic stellate cells
Fibrocytes	Blood, buffy coat	Flow cytometry of CD34⁺, CD45⁺, Coll I⁺ cells qPCR	Supplementation of local fibroblasts at site of liver injury by bone-marrow derived fibrocytes
BMP-7	Serum	Immunoassay	Antagonist of TGF-β, inhibitor of EMT
G-CSF	Blood	Immunoassays	Mobilization of bone-marrow derived fibrocytes
GM-CSF
M-CSF
Proteomics	Serum	Mass spectrometry (MS)	Fibrosis-specific serum protein profiles
Glycomics	Serum	Adaptation of DNA-sequencer/fragment analyzer technology to profiling of desialylated N-linked oligo-saccharides	Fibrosis-specific profiles of desialylated serum protein linked oligosaccharides (N-glycans)
Xylosyl-transferase (EC 2.4.2.26)	Serum	LC-MS/MS	Key enzyme in the biosynthesis of glycosaminoglycan chains in proteoglycans, e.g. in hepatic stellate cells and hepatocytes

Full Size Table

Citation: Gressner AM, Gao CF, Gressner OA. Non-invasive biomarkers for monitoring the fibrogenic process in liver: A short survey. World J Gastroenterol 2009; 15(20): 2433-2440
URL: https://www.wjgnet.com/1007-9327/full/v15/i20/2433.htm
DOI: https://dx.doi.org/10.3748/wjg.15.2433